Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition
-
* Corresponding author: Isabel Correa i.correa@icrf.icnet.uk
Breast Cancer Res 2001, 3:399-403 doi:10.1186/bcr330
Accesses
- Last 30 days: 44 accesses
- Last 365 days: 543 accesses
- All time: 5732 accesses
Cited by
BioMed Central: 1 citation
|
Research article
Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma Christina S Mullins, Sven Eisold, Ernst Klar, Michael Linnebacher BMC Immunology 2011, 12:38 (10 July 2011) |
